Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Opty / Re: Notes from the PTSC SHM meeting in Chicago - 1/28/2010

Yes, I am willing to consider the same direction OR other directions, but NOT with the same people. Put it this way, and I'll clearly exagerate for effect since some of these people have already passed, but if our new BOD members included GE's Jack Welch, Apple's Steven Jobs, Warren Buffet, Boeing's Bill Allen, Merck & Co.'s George Merck, and Sam Walton, I'd be pretty much willing to consider everything and anything they propose. Additionally, I'm confident, they'd find a way to make any of the strategies this BOD has considered or is considering, successful.

So the point is, the opportunity cost of keeping this BoD, even in the face of selecting one that might not be perfectly aligned with a strategy moving forward has proven to be high. They have been unable to select managers to execute on thier vision, and they have been unable to articulate a direction on which managers can successfully execute.

So, in response, I understand your point, but at this point, it is like saying it's more important for a passenger to have a destination in mind as they get into the cab of a blind cabbie and start moving than for that person to be in the cab of driver who can see, even if they don't quite know where they're going yet.

Share
New Message
Please login to post a reply